EBEN SOLIZ: Open Payments
NPI 1003043662 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,111 in 42 payments from 13 companies in 2025. Trend: 2023 $1,934 · 2024 $2,409 · 2025 $1,111
Food & beverage: $1,037Education: $74
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $340 |
| GENZYME CORPORATION | 11 | $206 |
| AstraZeneca Pharmaceuticals LP | 5 | $193 |
| Galderma Laboratories, L.P. | 1 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| LEO Pharma Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $27 |
| Optinose US, Inc. | 1 | $23 |
Products named: DUPIXENT, TEZSPIRE, NEMLUVIO, AIRSUPRA, CUVITRU, ADBRY, XOLAIR, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
